- Telehealth Visits
- Insurance plan information
Yosra El-Menshawi, DO
She | Her | HersChild and Adolescent Psychiatry • Adolescent Medicine- Telehealth Visits
- Insurance plan information
Yosra El-Menshawi, DO
She | Her | HersChild and Adolescent Psychiatry • Adolescent Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Yosra El-Menshawi is a psychiatrist who cares for hospitalized adolescents experiencing a mental health crisis. She helps stabilize and treat patients until they can transition to the appropriate next level of care.
El-Menshawi earned her doctor of osteopathic medicine degree from Lake Erie College of Osteopathic Medicine. She completed a residency in psychiatry at Loma Linda University, followed by a fellowship in child and adolescent psychiatry at the University of California, Los Angeles.
This provider works with UCSF through the UCSF Health Community Medical Group, a multispecialty group connecting doctors and practices throughout the Bay Area.
Education & training
Board certification
- Child & Adolescent Psychiatry, American Board of Medical Specialties
- Psychiatry, American Board of Medical Specialties
Fellowship
- Child and Adolescent Psychiatry, Harbor / UCLA Medical Center
Residency
- Psychiatry, Loma Linda University Hospital Medical Center
Degree
- DO, Lake Erie College of Osteopathic Medicine
My expertise
Specialties
- Child and Adolescent Psychiatry
- Adolescent Medicine
Clinical Trials query: q=health_gateway_id_ss%3A%28%223059%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223059%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.